Jean Jacovella

Superiority of ivermectin 1% cream over metronidazole 0·75% cream in treating inflammatory lesions of rosacea: a randomized, investigator-blinded trial

J P Ortonne, Thomas Ruzicka, Jadwiga Roszkiewicz et al. · British Journal of Dermatology · 2014 · 175 citations

Medicine, Dermatology, Pharmacotherapy +17

Efficacy and safety of ivermectin 1% cream in treatment of papulopustular rosacea: results of two randomized, double-blind, vehicle-controlled pivotal studies.

Linda Stein, Leon Kircik, Joseph F. Fowler et al. · PubMed · 2014 · 163 citations

Medicine, Dermatology, Pharmacology +14

Long-term safety of ivermectin 1% cream vs azelaic acid 15% gel in treating inflammatory lesions of rosacea: results of two 40-week controlled, investigator-blinded trials.

Linda Stein Gold, Leon Kircik, Joseph E. Fowler et al. · PubMed · 2014 · 65 citations

Medicine, Dermatology, Immunology +16

Maintenance of remission following successful treatment of papulopustular rosacea with ivermectin 1% cream vs. metronidazole 0.75% cream: 36‐week extension of the <scp>ATTRACT</scp> randomized study

A. Khemis, Thomas Ruzicka, Wioletta Barańska‐Rybak et al. · Journal of the European Academy of Dermatology and Venereology · 2015 · 55 citations

Pharmacy, Dermatology, Pharmacotherapy +8

Superior Efficacy with Ivermectin 1% Cream Compared to Metronidazole 0.75% Cream Contributes to a Better Quality of Life in Patients with Severe Papulopustular Rosacea: A Subanalysis of the Randomized, Investigator-Blinded ATTRACT Study

Martin Schaller, Thomas Dirschka, Lajos Kemény et al. · Dermatology and Therapy · 2016 · 35 citations · Full text

Medicine, Dermatology, Pharmacotherapy +15